NASDAQ: SIGASiga Technologies Inc Stock
$5.74+0.19 (+3.42%)
Updated Mar 24, 2023
SIGA Price
$5.74
Fair Value Price
$7.08
Market Cap
$414.43M
52 Week Low
$5.11
52 Week High
$26.99
P/E
12.48x
P/B
2.44x
P/S
4.85x
PEG
0.35x
Dividend Yield
7.84%
Revenue
$110.78M
Earnings
$33.90M
Gross Margin
90.6%
Operating Margin
39.84%
Profit Margin
30.6%
Debt to Equity
0.15
Operating Cash Flow
$42M
Beta
0.82
Next Earnings
May 3, 2023
Ex-Dividend
N/A
Next Dividend
N/A
SIGA Overview
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
Zen Score
–
Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SIGA scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SIGA ($5.74) is undervalued by 18.96% relative to our estimate of its Fair Value price of $7.08 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
SIGA ($5.74) is not significantly undervalued (18.96%) relative to our estimate of its Fair Value price of $7.08 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
SIGA ($5.74) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more SIGA due diligence checks available for Premium users.
Be the first to know about important SIGA news, forecast changes, insider trades & much more!
SIGA News
Valuation
SIGA fair value
Fair Value of SIGA stock based on Discounted Cash Flow (DCF)
Price
$5.74
Fair Value
$7.08
Undervalued by
18.96%
SIGA ($5.74) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SIGA ($5.74) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SIGA ($5.74) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
SIGA price to earnings (PE)
For valuing profitable companies with steady earnings
Company
12.48x
Industry
17.88x
Market
21.37x
SIGA is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
SIGA is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
SIGA price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.44x
Industry
4.89x
SIGA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SIGA price to earnings growth (PEG)
For valuing profitable companies with growth potential
SIGA is good value based... subscribe to Premium to read more.
PEG Value Valuation
SIGA's financial health
Profit margin
Revenue
$11.4M
Net Income
-$811.8k
Profit Margin
-7.1%
SIGA's Earnings (EBIT) of $44.13M... subscribe to Premium to read more.
Interest Coverage Financials
SIGA's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$195.0M
Liabilities
$24.9M
Debt to equity
0.15
SIGA's short-term assets ($185.79M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SIGA's short-term assets ($185.79M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SIGA's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SIGA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$8.1M
Investing
$0.0
Financing
-$2.9M
SIGA's operating cash flow ($41.61M)... subscribe to Premium to read more.
Debt Coverage Financials
SIGA vs Biotech Stocks
Siga Technologies Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.